Indeed, a recent study revealed the role of MUC5AC, MUC1 and proteoglycans in the inhibition of E-cadherin function associated with invasiveness of HT-29 colon adenocarcinoma cell variants (Truant et al, 2003). Here, MUC1 is linked to colon adenocarcinoma.